BBI-801

N/A

Report date: 2024/11/28 15:05:24

Base Information

Drug NameBBI-801
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionCatenin beta 1 inhibitorsProgrammed death-ligand 1 blockers
TargetsCatenin beta 1Programmed death-ligand 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBoston Biomedical Inc
China Registration ClassN/A

Develop Information

Active CompaniesBoston Biomedical Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A